Celltran

CellTran Limited in Administration

C. Escott and W. Duncan of PKF (UK) LLP were appointed joint administrators 30 May 2008. The business is being managed by the joint administrators.

All enquiries should be directed to Gareth Lewis on:-
Tel: 0113 228 4155 or Fax: 0113 228 4242

Specialists in tissue regeneration

CellTran are leaders in the field of regenerative wound healing. Our primary focus is the early development and clinical availability of novel treatments that repair tissue and bring tangible improvements to the health, well-being and quality of life of patients.

Our activities include research and development of products for the regeneration of tissue and the healing of wounds, using both the patient's own or donor sources in a range of presentations to best suit the clinical need.

CellTran's flagship product, Myskin™, was launched in 2005 and is the first in a range of products specifically developed to treat burns and other skin wounds.

Lyphoderm, which will be globally accessible for the treatment of chronic wounds, is entering phase III clinical trials.